Standout Papers
- European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update (2024)
- European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) (2021)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update (2023)
Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of A. Masson-Lecomte being referenced
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
2021 Standout
Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A. Masson-Lecomte | 1547 | 421 | 636 | 438 | 85 | 2.1k | |
| Ho Kyung Seo | 1074 | 304 | 726 | 483 | 139 | 2.0k | |
| Marek Babjuk | 1523 | 501 | 337 | 398 | 83 | 2.0k | |
| Renate Pichler | 1003 | 364 | 654 | 418 | 138 | 1.9k | |
| Jorg R. Oddens | 1536 | 565 | 1077 | 302 | 66 | 2.6k | |
| Francesco Soria | 1894 | 582 | 535 | 295 | 136 | 2.4k | |
| Joost L. Boormans | 1449 | 288 | 813 | 717 | 125 | 2.3k | |
| Andrew T. Lenis | 1152 | 226 | 614 | 653 | 74 | 2.0k | |
| Joan Palou Redorta | 1296 | 616 | 664 | 312 | 65 | 2.0k | |
| Anna Orsola | 1290 | 381 | 786 | 353 | 64 | 2.2k | |
| Fabien Saint | 1565 | 591 | 1339 | 511 | 65 | 2.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...